Search

Mauris Desilva

from Burnsville, MN
Age ~50
Get Report
Also known as:
Mavris Desilva, Mauris Silva
Related to:
Athige D Desilva, 58James SilvaJoanie Desilva, 77James Silva, 48Helio R Dasilva, 60Solange S Bezerra, 60Athige Denzil Desilva, 78Maria Z Medeiros, 58
Connected to:
Alexis Desilva, 31Alicia V Desilva, 96Anula S Desilva, 67Asanka H Desilva, 52Betty G Desilva, 80Brandon D Desilva, 39Carmen H Desilva, 76Donnajean Desilva, 76Donneta Desilva, 60Indrani G Desilva, 49

Mauris Desilva Phones & Addresses

  • Burnsville, MN
  • 300 Bowie St APT 1708, Austin, TX 78703 (305) 562-7816
  • Chicago, IL
  • 7720 Penn Ave S, Minneapolis, MN 55423
  • Richfield, MN
  • Evanston, IL
  • San Antonio, TX
  • Miami, FL
  • 300 Bowie St APT 1708, Austin, TX 78703

Publications

Us Patents

Nano-Encapsulated Therapeutics For Controlled Treatment Of Infection And Other Diseases

View page
US Patent:
20130089599, Apr 11, 2013
Filed:
Jun 10, 2012
Appl. No.:
13/492889
Inventors:
Mauris N. DeSilva - Austin TX, US
Karen O'Connor - Scoresby, AU
Amer Tiba - Chicago IL, US
Assignee:
The United States of America as Represented by the Secretary of the Navy - Arlington VA
International Classification:
A61K 9/51
US Classification:
424450, 424490, 424493, 977773, 977906, 977907
Abstract:
This invention relates to a method to provide immediate, direct and controlled time release of an effective amount of therapeutics to a wound site for a prolonged period. The pharmaceutical formulation comprising a plurality of nanoparticles, said nanoparticles encapsulating a therapeutically effective amount of one or more antibacterial agents, and an application of the formulation to an implant before surgery provide for extended release of said antibacterial agents.

Method For Predicting Autism Spectrum Disorders By Cannabinoid And Cannabinoid Receptor Expression

View page
US Patent:
20120225015, Sep 6, 2012
Filed:
Mar 3, 2012
Appl. No.:
13/411538
Inventors:
Stephen T. Schultz - San Antonio TX, US
Mauris N. DeSilva - Austin TX, US
Georgianna G. Gould - San Antonio TX, US
International Classification:
A61K 51/04
G01N 27/62
A61K 49/00
US Classification:
424 165, 424 91, 436501
Abstract:
The inventive method relates to a method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expression.
Control profile
Mauris Desilva from Burnsville, MN, age ~50 Get Report